Pure Global
NCT01208142

Toe Walker Gait Trial

Dynamic Splinting for Toe Walking: a Randomized, Controlled Study With Gait Analysis
Dynasplint Systems, Inc.·ClinicalTrials.gov·otherTerminated
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Gait
Drug/Device/Intervention
standard of care treatment
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Dynasplint Systems, Inc.
Location
Columbus,Lubbock, United States of America
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2010
End date
N/A
Enrollment
10 participants
Primary outcome

Change in plantar flexion while ambulating

Summary

The purpose of this study is to examine the change in ankle plantar flexion while walking,
 following treatment with the Ankle Dorsiflexion Dynasplint (AFD) for children diagnosed as
 Toe Walkers.
 
 For twelve weeks, patients will either receive the standard treatment or the same standard
 treatment and the Dynaslint worn at night.

ICD-10 classifications
Paralytic gaitAbnormalities of gait and mobilityOther and unspecified abnormalities of gait and mobilityAtaxic gaitFall on and from stairs and steps
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT01208142
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT01208142 through Pure Global AI's free database. This phase not specified trial is sponsored by Dynasplint Systems, Inc. and is currently Terminated. The study focuses on Gait. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.